AMKD | Docwire News

AMKD

Keightley Amen, BA, ELSNephrology Times | April 15, 2025

Dr. Daryl Crenshaw gave a detailed review of the significance of the APOL1 gene at the NephCure 2025 Patient Summit.

Cesia Portillo, MPHNKF Spring Clinical Meetings 2024 | June 4, 2024

Cesia Portillo discussed her poster on creating a roadmap for APOL1-mediated kidney disease (AMKD).

A roadmap created by the Kidney Health Initiative provides tangible ways to better address APOL1-mediated kidney disease.

Charlotte RobinsonIgA Nephropathy | April 12, 2024

Vertex Pharmaceuticals will acquire Alpine Immune Sciences, developer of povetacicept for IgA nephropathy.